<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35871163</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>23</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Human iPSC co-culture model to investigate the interaction between microglia and motor neurons.</ArticleTitle><Pagination><StartPage>12606</StartPage><MedlinePgn>12606</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">12606</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-022-16896-8</ELocationID><Abstract><AbstractText>Motor neuron diseases such as amyotrophic lateral sclerosis are primarily characterized by motor neuron degeneration with additional involvement of non-neuronal cells, in particular, microglia. In previous work, we have established protocols for the differentiation of iPSC-derived spinal motor neurons and microglia. Here, we combine both cell lineages and establish a novel co-culture of iPSC-derived spinal motor neurons and microglia, which is compatible with motor neuron identity and function. Co-cultured microglia express key identity markers and transcriptomically resemble primary human microglia, have highly dynamic ramifications, are phagocytically competent, release relevant cytokines and respond to stimulation. Further, they express key amyotrophic lateral sclerosis-associated genes and release disease-relevant biomarkers. This novel and authentic human model system facilitates the study of physiological motor neuron-microglia crosstalk and will allow the investigation of non-cell-autonomous phenotypes in motor neuron diseases such as amyotrophic lateral sclerosis.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vahsen</LastName><ForeName>Bj&#xf6;rn F</ForeName><Initials>BF</Initials><AffiliationInfo><Affiliation>Oxford Motor Neuron Disease Centre, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, OX3 9DU, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford, OX1 3QU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gray</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Oxford Motor Neuron Disease Centre, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, OX3 9DU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Candalija</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Oxford Motor Neuron Disease Centre, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, OX3 9DU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cramb</LastName><ForeName>Kaitlyn M L</ForeName><Initials>KML</Initials><AffiliationInfo><Affiliation>Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford, OX1 3QU, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oxford Parkinson's Disease Centre, Department of Physiology, Anatomy and Genetics, University of Oxford, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford, OX1 3QX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scaber</LastName><ForeName>Jakub</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Oxford Motor Neuron Disease Centre, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, OX3 9DU, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford, OX1 3QU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dafinca</LastName><ForeName>Ruxandra</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Oxford Motor Neuron Disease Centre, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, OX3 9DU, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford, OX1 3QU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katsikoudi</LastName><ForeName>Antigoni</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford, OX1 3QU, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Neurodegeneration Research Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford, OX1 3QU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Yinyan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Oxford Motor Neuron Disease Centre, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, OX3 9DU, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford, OX1 3QU, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chinese Academy of Medical Sciences (CAMS), CAMS Oxford Institute (COI), Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farrimond</LastName><ForeName>Lucy</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Oxford Motor Neuron Disease Centre, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, OX3 9DU, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford, OX1 3QU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wade-Martins</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford, OX1 3QU, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oxford Parkinson's Disease Centre, Department of Physiology, Anatomy and Genetics, University of Oxford, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford, OX1 3QX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>James</LastName><ForeName>William S</ForeName><Initials>WS</Initials><AffiliationInfo><Affiliation>James and Lillian Martin Centre for Stem Cell Research, Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, OX1 3RE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>Martin R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Oxford Motor Neuron Disease Centre, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, OX3 9DU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cowley</LastName><ForeName>Sally A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>James and Lillian Martin Centre for Stem Cell Research, Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, OX1 3RE, UK. sally.cowley@path.ox.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talbot</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Oxford Motor Neuron Disease Centre, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, OX3 9DU, UK. kevin.talbot@ndcn.ox.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford, OX1 3QU, UK. kevin.talbot@ndcn.ox.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/P007058/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>K-1003</GrantID><Acronym>PUK_</Acronym><Agency>Parkinson's UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G-1003</GrantID><Acronym>PUK_</Acronym><Agency>Parkinson's UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>TALBOT/OCT15/886-792</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/N029453/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>H-1102</GrantID><Acronym>PUK_</Acronym><Agency>Parkinson's UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/M024962/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>H-1301</GrantID><Acronym>PUK_</Acronym><Agency>Parkinson's UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/P007023/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>TALBOT-MUTIHAC/APR15/832-791</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_EX_MR/N50192X/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/L023784/2</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>TURNER/OCT18/989-797</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>203141/Z/16/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>J-0901</GrantID><Acronym>PUK_</Acronym><Agency>Parkinson's UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>WADE-MARTINS/OCT13/867-792</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018920" MajorTopicYN="N">Coculture Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>23</Day><Hour>23</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35871163</ArticleId><ArticleId IdType="pmc">PMC9308778</ArticleId><ArticleId IdType="doi">10.1038/s41598-022-16896-8</ArticleId><ArticleId IdType="pii">10.1038/s41598-022-16896-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ilieva H, Polymenidou M, Cleveland DW. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 2009;187:761&#x2013;772. doi: 10.1083/jcb.200908164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200908164</ArticleId><ArticleId IdType="pmc">PMC2806318</ArticleId><ArticleId IdType="pubmed">19951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Kankel MW, Su SC, Han SWS, Ofengeim D. Exploring the genetics and non-cell autonomous mechanisms underlying ALS/FTLD. Cell Death Differ. 2018;25:648&#x2013;662. doi: 10.1038/s41418-018-0060-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-018-0060-4</ArticleId><ArticleId IdType="pmc">PMC5864209</ArticleId><ArticleId IdType="pubmed">29459769</ArticleId></ArticleIdList></Reference><Reference><Citation>Serio A, Patani R. Concise review: The cellular conspiracy of amyotrophic lateral sclerosis. Stem Cells. 2018;36:293&#x2013;303. doi: 10.1002/stem.2758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2758</ArticleId><ArticleId IdType="pubmed">29235200</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi S, Cozzolino M, Carri MT. Old versus new mechanisms in the pathogenesis of ALS. Brain Pathol. 2016;26:276&#x2013;286. doi: 10.1111/bpa.12355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12355</ArticleId><ArticleId IdType="pmc">PMC8029354</ArticleId><ArticleId IdType="pubmed">26779612</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahsen BF, et al. Non-neuronal cells in amyotrophic lateral sclerosis&#x2014;From pathogenesis to biomarkers. Nat. Rev. Neurol. 2021;17:333&#x2013;348. doi: 10.1038/s41582-021-00487-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-021-00487-8</ArticleId><ArticleId IdType="pubmed">33927394</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: An [11C](R)-PK11195 positron emission tomography study. Neurobiol. Dis. 2004;15:601&#x2013;609. doi: 10.1016/j.nbd.2003.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2003.12.012</ArticleId><ArticleId IdType="pubmed">15056468</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeer PL, Itagaki S, McGeer EG. Expression of the histocompatibility glycoprotein HLA-DR in neurological disease. Acta Neuropathol. 1988;76:550&#x2013;557. doi: 10.1007/BF00689592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00689592</ArticleId><ArticleId IdType="pubmed">2974227</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson AG, et al. Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis. Ann. Neurol. 2018;83:258&#x2013;268. doi: 10.1002/ana.25143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25143</ArticleId><ArticleId IdType="pubmed">29331073</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson AG, et al. CSF chitinase proteins in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2019;90:1215&#x2013;1220. doi: 10.1136/jnnp-2019-320442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-320442</ArticleId><ArticleId IdType="pubmed">31123140</ArticleId></ArticleIdList></Reference><Reference><Citation>Colonna M, Butovsky O. Microglia function in the central nervous system during health and neurodegeneration. Annu. Rev. Immunol. 2017;35:441&#x2013;468. doi: 10.1146/annurev-immunol-051116-052358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-051116-052358</ArticleId><ArticleId IdType="pmc">PMC8167938</ArticleId><ArticleId IdType="pubmed">28226226</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Rourke JG, et al. C9orf72 is required for proper macrophage and microglial function in mice. Science. 2016;351:1324&#x2013;1329. doi: 10.1126/science.aaf1064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf1064</ArticleId><ArticleId IdType="pmc">PMC5120541</ArticleId><ArticleId IdType="pubmed">26989253</ArticleId></ArticleIdList></Reference><Reference><Citation>Boillee S, et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006;312:1389&#x2013;1392. doi: 10.1126/science.1123511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123511</ArticleId><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Lall D, et al. C9orf72 deficiency promotes microglial-mediated synaptic loss in aging and amyloid accumulation. Neuron. 2021;109:2275&#x2013;2291. doi: 10.1016/j.neuron.2021.05.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2021.05.020</ArticleId><ArticleId IdType="pmc">PMC8298293</ArticleId><ArticleId IdType="pubmed">34133945</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley ME, et al. C9orf72 in myeloid cells suppresses STING-induced inflammation. Nature. 2020;585:96&#x2013;101. doi: 10.1038/s41586-020-2625-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2625-x</ArticleId><ArticleId IdType="pmc">PMC7484469</ArticleId><ArticleId IdType="pubmed">32814898</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf SA, Boddeke HW, Kettenmann H. Microglia in physiology and disease. Annu. Rev. Physiol. 2017;79:619&#x2013;643. doi: 10.1146/annurev-physiol-022516-034406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-physiol-022516-034406</ArticleId><ArticleId IdType="pubmed">27959620</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso R, et al. Stem-cell-derived human microglia transplanted in mouse brain to study human disease. Nat. Neurosci. 2019;22:2111&#x2013;2116. doi: 10.1038/s41593-019-0525-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0525-x</ArticleId><ArticleId IdType="pubmed">31659342</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacomelli E, et al. Human stem cell models of neurodegeneration: From basic science of amyotrophic lateral sclerosis to clinical translation. Cell Stem Cell. 2022;29:11&#x2013;35. doi: 10.1016/j.stem.2021.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2021.12.008</ArticleId><ArticleId IdType="pmc">PMC8785905</ArticleId><ArticleId IdType="pubmed">34995492</ArticleId></ArticleIdList></Reference><Reference><Citation>Dafinca R, et al. C9orf72 hexanucleotide expansions are associated with altered endoplasmic reticulum calcium homeostasis and stress granule formation in induced pluripotent stem cell-derived neurons from patients with amyotrophic lateral sclerosis and frontotemporal dementia. Stem Cells. 2016;34:2063&#x2013;2078. doi: 10.1002/stem.2388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2388</ArticleId><ArticleId IdType="pmc">PMC4979662</ArticleId><ArticleId IdType="pubmed">27097283</ArticleId></ArticleIdList></Reference><Reference><Citation>Dafinca R, et al. Impairment of mitochondrial calcium buffering links mutations in C9ORF72 and TARDBP in iPS-derived motor neurons from patients with ALS/FTD. Stem Cell Rep. 2020;14:892&#x2013;908. doi: 10.1016/j.stemcr.2020.03.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2020.03.023</ArticleId><ArticleId IdType="pmc">PMC7220989</ArticleId><ArticleId IdType="pubmed">32330447</ArticleId></ArticleIdList></Reference><Reference><Citation>van Wilgenburg B, Browne C, Vowles J, Cowley SA. Efficient, long term production of monocyte-derived macrophages from human pluripotent stem cells under partly-defined and fully-defined conditions. PLoS ONE. 2013;8:e71098. doi: 10.1371/journal.pone.0071098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0071098</ArticleId><ArticleId IdType="pmc">PMC3741356</ArticleId><ArticleId IdType="pubmed">23951090</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlsson KR, et al. Homogeneous monocytes and macrophages from human embryonic stem cells following coculture-free differentiation in M-CSF and IL-3. Exp. Hematol. 2008;36:1167&#x2013;1175. doi: 10.1016/j.exphem.2008.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exphem.2008.04.009</ArticleId><ArticleId IdType="pmc">PMC2635571</ArticleId><ArticleId IdType="pubmed">18550257</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchrieser J, James W, Moore MD. Human induced pluripotent stem cell-derived macrophages share ontogeny with MYB-independent tissue-resident macrophages. Stem Cell Rep. 2017;8:334&#x2013;345. doi: 10.1016/j.stemcr.2016.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2016.12.020</ArticleId><ArticleId IdType="pmc">PMC5312255</ArticleId><ArticleId IdType="pubmed">28111278</ArticleId></ArticleIdList></Reference><Reference><Citation>Monier A, et al. Entry and distribution of microglial cells in human embryonic and fetal cerebral cortex. J. Neuropathol. Exp. Neurol. 2007;66:372&#x2013;382. doi: 10.1097/nen.0b013e3180517b46.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/nen.0b013e3180517b46</ArticleId><ArticleId IdType="pubmed">17483694</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezaie P, Dean A, Male D, Ulfig N. Microglia in the cerebral wall of the human telencephalon at second trimester. Cereb. Cortex. 2005;15:938&#x2013;949. doi: 10.1093/cercor/bhh194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhh194</ArticleId><ArticleId IdType="pubmed">15483047</ArticleId></ArticleIdList></Reference><Reference><Citation>Greter M, et al. Stroma-derived interleukin-34 controls the development and maintenance of Langerhans cells and the maintenance of microglia. Immunity. 2012;37:1050&#x2013;1060. doi: 10.1016/j.immuni.2012.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2012.11.001</ArticleId><ArticleId IdType="pmc">PMC4291117</ArticleId><ArticleId IdType="pubmed">23177320</ArticleId></ArticleIdList></Reference><Reference><Citation>Haenseler W, et al. A highly efficient human pluripotent stem cell microglia model displays a neuronal-co-culture-specific expression profile and inflammatory response. Stem Cell Rep. 2017;8:1727&#x2013;1742. doi: 10.1016/j.stemcr.2017.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.05.017</ArticleId><ArticleId IdType="pmc">PMC5470330</ArticleId><ArticleId IdType="pubmed">28591653</ArticleId></ArticleIdList></Reference><Reference><Citation>Ababneh NA, et al. Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR/Cas9 genome editing using homology-directed repair. Hum. Mol. Genet. 2020;29:2200&#x2013;2217. doi: 10.1093/hmg/ddaa106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddaa106</ArticleId><ArticleId IdType="pmc">PMC7399532</ArticleId><ArticleId IdType="pubmed">32504093</ArticleId></ArticleIdList></Reference><Reference><Citation>Abud EM, et al. iPSC-derived human microglia-like cells to study neurological diseases. Neuron. 2017;94:278&#x2013;293. doi: 10.1016/j.neuron.2017.03.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.03.042</ArticleId><ArticleId IdType="pmc">PMC5482419</ArticleId><ArticleId IdType="pubmed">28426964</ArticleId></ArticleIdList></Reference><Reference><Citation>Muffat J, et al. Efficient derivation of microglia-like cells from human pluripotent stem cells. Nat. Med. 2016;22:1358&#x2013;1367. doi: 10.1038/nm.4189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4189</ArticleId><ArticleId IdType="pmc">PMC5101156</ArticleId><ArticleId IdType="pubmed">27668937</ArticleId></ArticleIdList></Reference><Reference><Citation>Galatro TF, et al. Transcriptomic analysis of purified human cortical microglia reveals age-associated changes. Nat. Neurosci. 2017;20:1162&#x2013;1171. doi: 10.1038/nn.4597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4597</ArticleId><ArticleId IdType="pubmed">28671693</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O, et al. Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat. Neurosci. 2014;17:131&#x2013;143. doi: 10.1038/nn.3599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3599</ArticleId><ArticleId IdType="pmc">PMC4066672</ArticleId><ArticleId IdType="pubmed">24316888</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett ML, et al. New tools for studying microglia in the mouse and human CNS. Proc. Natl. Acad. Sci. U S A. 2016;113:E1738&#x2013;1746. doi: 10.1073/pnas.1525528113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1525528113</ArticleId><ArticleId IdType="pmc">PMC4812770</ArticleId><ArticleId IdType="pubmed">26884166</ArticleId></ArticleIdList></Reference><Reference><Citation>Melief J, et al. Phenotyping primary human microglia: Tight regulation of LPS responsiveness. Glia. 2012;60:1506&#x2013;1517. doi: 10.1002/glia.22370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22370</ArticleId><ArticleId IdType="pubmed">22740309</ArticleId></ArticleIdList></Reference><Reference><Citation>Pocock JM, Piers TM. Modelling microglial function with induced pluripotent stem cells: An update. Nat. Rev. Neurosci. 2018;19:445&#x2013;452. doi: 10.1038/s41583-018-0030-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-018-0030-3</ArticleId><ArticleId IdType="pubmed">29977068</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes HJ, et al. ER stress and autophagic perturbations lead to elevated extracellular alpha-synuclein in GBA-N370S Parkinson's iPSC-derived dopamine neurons. Stem Cell Rep. 2016;6:342&#x2013;356. doi: 10.1016/j.stemcr.2016.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2016.01.013</ArticleId><ArticleId IdType="pmc">PMC4788783</ArticleId><ArticleId IdType="pubmed">26905200</ArticleId></ArticleIdList></Reference><Reference><Citation>Haenseler W, et al. Excess alpha-synuclein compromises phagocytosis in iPSC-derived macrophages. Sci. Rep. 2017;7:9003. doi: 10.1038/s41598-017-09362-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-09362-3</ArticleId><ArticleId IdType="pmc">PMC5567139</ArticleId><ArticleId IdType="pubmed">28827786</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonikas M, et al. Stem cell modeling of mitochondrial parkinsonism reveals key functions of OPA1. Ann. Neurol. 2018;83:915&#x2013;925. doi: 10.1002/ana.25221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25221</ArticleId><ArticleId IdType="pmc">PMC6032926</ArticleId><ArticleId IdType="pubmed">29604226</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughan-Jackson A, et al. Differentiation of human induced pluripotent stem cells to authentic macrophages using a defined, serum-free, open-source medium. Stem Cell Rep. 2021;16:1735&#x2013;1748. doi: 10.1016/j.stemcr.2021.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.05.018</ArticleId><ArticleId IdType="pmc">PMC8282471</ArticleId><ArticleId IdType="pubmed">34171284</ArticleId></ArticleIdList></Reference><Reference><Citation>York EM, LeDue JM, Bernier LP, MacVicar BA. 3DMorph automatic analysis of microglial morphology in three dimensions from ex vivo and in vivo imaging. eNeuro. 2018 doi: 10.1523/ENEURO.0266-18.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/ENEURO.0266-18.2018</ArticleId><ArticleId IdType="pmc">PMC6325541</ArticleId><ArticleId IdType="pubmed">30627639</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiry L, Hamel R, Pluchino S, Durcan T, Stifani S. Characterization of human iPSC-derived spinal motor neurons by single-cell RNA sequencing. Neuroscience. 2020;450:57&#x2013;70. doi: 10.1016/j.neuroscience.2020.04.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2020.04.041</ArticleId><ArticleId IdType="pubmed">32380268</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamble S, et al. Improved workflows for high throughput library preparation using the transposome-based Nextera system. BMC Biotechnol. 2013;13:104. doi: 10.1186/1472-6750-13-104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6750-13-104</ArticleId><ArticleId IdType="pmc">PMC4222894</ArticleId><ArticleId IdType="pubmed">24256843</ArticleId></ArticleIdList></Reference><Reference><Citation>Ewels P, Magnusson M, Lundin S, Kaller M. MultiQC: Summarize analysis results for multiple tools and samples in a single report. Bioinformatics. 2016;32:3047&#x2013;3048. doi: 10.1093/bioinformatics/btw354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw354</ArticleId><ArticleId IdType="pmc">PMC5039924</ArticleId><ArticleId IdType="pubmed">27312411</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D, Paggi JM, Park C, Bennett C, Salzberg SL. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 2019;37:907&#x2013;915. doi: 10.1038/s41587-019-0201-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-019-0201-4</ArticleId><ArticleId IdType="pmc">PMC7605509</ArticleId><ArticleId IdType="pubmed">31375807</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, et al. The sequence alignment/map format and SAMtools. Bioinformatics. 2009;25:2078&#x2013;2079. doi: 10.1093/bioinformatics/btp352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp352</ArticleId><ArticleId IdType="pmc">PMC2723002</ArticleId><ArticleId IdType="pubmed">19505943</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y, Smyth GK, Shi W. featureCounts: An efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923&#x2013;930. doi: 10.1093/bioinformatics/btt656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btt656</ArticleId><ArticleId IdType="pubmed">24227677</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. doi: 10.1186/s13059-014-0550-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-014-0550-8</ArticleId><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephens M. False discovery rates: A new deal. Biostatistics. 2017;18:275&#x2013;294. doi: 10.1093/biostatistics/kxw041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biostatistics/kxw041</ArticleId><ArticleId IdType="pmc">PMC5379932</ArticleId><ArticleId IdType="pubmed">27756721</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G, Wang LG, Han Y, He QY. clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS. 2012;16:284&#x2013;287. doi: 10.1089/omi.2011.0118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/omi.2011.0118</ArticleId><ArticleId IdType="pmc">PMC3339379</ArticleId><ArticleId IdType="pubmed">22455463</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>